Po W Wang1, Napapon Sailasuta2, Rebecca A Chandler3, Terence A Ketter1. 1. 1Department of Psychiatry and Behavioral Sciences, Bipolar Disorders Clinic, Stanford University School of Medicine, Stanford, CA, USA. 2. 2Department of Medicine, University of Hawaii, Honolulu, HI ,USA. 3. 3Department of Psychiatry, Oxford University, Oxford, UK.
Abstract
BACKGROUND: Animal models of depression and psychopharmacological mechanisms of action suggest the importance of the gamma-amino butyric acid (GABA) system in the pathophysiology of mood disorders. Mood stabilizers have overlapping effects on GABAergic neurotransmission, and antidepressant use has been associated with alterations in GABAB receptor function. Magnetic resonance spectroscopy (MRS) provides an opportunity to noninvasively assess cerebral GABA concentrations in anterior paralimbic circuits that have been implicated in mood disorders. METHODS: In bipolar disorder patients and healthy control subjects, we used MRS with a modified GABA-edited point resolved spectroscopy sequence (TE 68 ms, TR 1500 ms, 512 averages, total scan time 26 min) to assess GABA in an 18-cm3 occipital voxel. In addition, in another cohort of bipolar disorder patients and healthy control subjects, we similarly assessed GABA in a 12.5-cm3 medial prefrontal/anterior cingulate (MPF/AC) voxel. The concentration of GABA was referenced to creatine (Cr) from unedited spectra. RESULTS: In bipolar patients and controls, we consistently detected 3.0 p.p.m. GABA peaks in occipital lobe and MPF/AC. In 16 bipolar (nine bipolar I and seven bipolar II) disorder patients, compared with six healthy control subjects, mean occipital GABA/Cr concentration was 61% higher. In addition, in 15 bipolar (five bipolar I, nine bipolar II, and one bipolar not otherwise specified) disorder patients, compared with six healthy control subjects, mean MPF/AC GABA/Cr concentration tended to be 41% higher. CONCLUSIONS: Patients with bipolar disorders may have increased cerebral GABA concentrations. Although this was more evident in the occipital lobe, MPC/AC GABA disturbance may be of greater potential interest in view the more established role of MPF/AC in affective processing. Additional studies are warranted to assess changes in GABAergic neurotransmission and the influences of diagnosis, mood state, and medication status in bipolar disorder patients.
BACKGROUND: Animal models of depression and psychopharmacological mechanisms of action suggest the importance of the gamma-amino butyric acid (GABA) system in the pathophysiology of mood disorders. Mood stabilizers have overlapping effects on GABAergic neurotransmission, and antidepressant use has been associated with alterations in GABAB receptor function. Magnetic resonance spectroscopy (MRS) provides an opportunity to noninvasively assess cerebral GABA concentrations in anterior paralimbic circuits that have been implicated in mood disorders. METHODS: In bipolar disorderpatients and healthy control subjects, we used MRS with a modified GABA-edited point resolved spectroscopy sequence (TE 68 ms, TR 1500 ms, 512 averages, total scan time 26 min) to assess GABA in an 18-cm3 occipital voxel. In addition, in another cohort of bipolar disorderpatients and healthy control subjects, we similarly assessed GABA in a 12.5-cm3 medial prefrontal/anterior cingulate (MPF/AC) voxel. The concentration of GABA was referenced to creatine (Cr) from unedited spectra. RESULTS: In bipolar patients and controls, we consistently detected 3.0 p.p.m. GABA peaks in occipital lobe and MPF/AC. In 16 bipolar (nine bipolar I and seven bipolar II) disorderpatients, compared with six healthy control subjects, mean occipital GABA/Cr concentration was 61% higher. In addition, in 15 bipolar (five bipolar I, nine bipolar II, and one bipolar not otherwise specified) disorder patients, compared with six healthy control subjects, mean MPF/ACGABA/Cr concentration tended to be 41% higher. CONCLUSIONS:Patients with bipolar disorders may have increased cerebral GABA concentrations. Although this was more evident in the occipital lobe, MPC/AC GABA disturbance may be of greater potential interest in view the more established role of MPF/AC in affective processing. Additional studies are warranted to assess changes in GABAergic neurotransmission and the influences of diagnosis, mood state, and medication status in bipolar disorderpatients.
Authors: James J Prisciandaro; William Mellick; Lindsay M Squeglia; Sara Hix; Lauren Arnold; Bryan K Tolliver Journal: Addict Biol Date: 2021-08-14 Impact factor: 4.093
Authors: Remmelt R Schür; Luc W R Draisma; Jannie P Wijnen; Marco P Boks; Martijn G J C Koevoets; Marian Joëls; Dennis W Klomp; René S Kahn; Christiaan H Vinkers Journal: Hum Brain Mapp Date: 2016-05-04 Impact factor: 5.038
Authors: Roscoe O Brady; Julie M McCarthy; Andrew P Prescot; J Eric Jensen; Alissa J Cooper; Bruce M Cohen; Perry F Renshaw; Dost Ongür Journal: Bipolar Disord Date: 2013-05-02 Impact factor: 6.744
Authors: Jonathan Chabert; Etienne Allauze; Bruno Pereira; Carine Chassain; Ingrid De Chazeron; Jean-Yves Rotgé; Philippe Fossati; Pierre-Michel Llorca; Ludovic Samalin Journal: Int J Mol Sci Date: 2022-08-11 Impact factor: 6.208
Authors: J J Prisciandaro; B K Tolliver; A P Prescot; H M Brenner; P F Renshaw; T R Brown; R F Anton Journal: Transl Psychiatry Date: 2017-07-04 Impact factor: 6.222
Authors: Tania Da Silva; Sina Hafizi; Ana C Andreazza; Michael Kiang; R Michael Bagby; Efren Navas; Isabelle Laksono; Peter Truong; Cory Gerritsen; Ivana Prce; Napapon Sailasuta; Romina Mizrahi Journal: Int J Neuropsychopharmacol Date: 2018-04-01 Impact factor: 5.176
Authors: Joseph J Shaffer; Merry Mani; Samantha L Schmitz; Jia Xu; Nana Owusu; Dee Wu; Vincent A Magnotta; John A Wemmie Journal: Front Psychiatry Date: 2020-09-24 Impact factor: 4.157